LongevityResearch peptide

FOXO4-DRI

FOXO4-DRI is a D-retro-inverso senolytic peptide engineered to disrupt the FOXO4-p53 interaction, selectively triggering apoptosis in senescent cells. It is studied in aging and tissue-regeneration models.

Also known as: FOXO4 D-Retro-Inverso, ES2

Technical information

Molecular weight

~5.5 kDa

Half-life

Not well characterized

Sequence

D-retro-inverso peptide (FOXO4 p53-interaction domain)

Common research doses

Preclinical only (research protocols)

Research areas

SenolyticsFOXO4-p53 disruptionCellular senescenceAging research

For research purposes only. PepAssure provides vendor information as a verification service and does not endorse or recommend any specific use. Consult qualified research protocols and institutional review boards.